Skip to main content
Premium Trial:

Request an Annual Quote

FDA Clears Prodesse RT-PCR Flu Test

NEW YORK (GenomeWeb News) – Prodesse has received US Food and Drug Administration clearance to market its real-time PCR-based flu test, the company said yesterday.
 
The firm’s ProFlu Assay is designed to simultaneously detect and differentiate influenza A and B viruses and respiratory syncytial virus, and provides results in around three hours.
 
Prodesse said other tests are on the way, including one for human metapneumovirus that is in clinical trials now and another to differentiate parainfluenza viruses that is soon to begin clinical trials.
 
Clearance of the Prodesse flu assay comes in the same week that the FDA cleared for marketing a respiratory viral panel from Luminex.
 
Luminex’s xTag Respiratory Viral Panel is based on the firm’s xMAP bead technology and targets 12 viruses that account for over 85 percent of respiratory viral infections, including various influenza strains.
 
Prodesse claims that its real-time PCR-based test would provide advantages, such as reduced hands-on time, elimination of amplicon contamination, and relatively low equipment costs, over other molecular diagnostic technologies including microbeads and microarrays.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.